Obesity and inflammation: a new look at an old problem

Area of Science:

• Cardiovascular Disease
• Endocrinology
• Immunology

Background:

• Obesity is a prevalent condition linked to increased cardiovascular morbidity and mortality.
• Traditionally, adipose tissue was considered a passive energy storage site.
• Emerging evidence highlights adipose tissue as an active endocrine organ influencing metabolic pathways.

Purpose of the Study:

• To explore the role of adipose tissue as an endocrine organ.
• To elucidate the mechanisms linking obesity, inflammation, and atherosclerosis.
• To discuss the interaction between obesity and cardiovascular risk factors.

Main Methods:

• Review of current literature on obesity, inflammation, and cardiovascular disease.
• Analysis of established and emerging inflammatory markers associated with adipose tissue.
• Examination of the interplay between metabolic pathways and cardiac risk factors.

Main Results:

• Adipose tissue actively synthesizes proteins involved in inflammation.
• Numerous inflammatory markers (e.g., C-reactive protein, adiponectin, TNF-alpha) are associated with obesity.
• Obesity is increasingly recognized as an inflammatory state contributing to atherosclerosis.

Conclusions:

• Obesity is a complex endocrine and inflammatory condition.
• Understanding these inflammatory pathways provides insights into atherosclerosis development.
• Obesity's role as an active endocrine organ necessitates a re-evaluation of cardiovascular risk management.